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Abstract
Background: An antiviral drug is needed for the treatment of patients suffering from yellow fever.
Several compounds present in plants can inactive in vitro a wide spectrum of animal viruses.
Aim: In the present study the inhibitory effect of essential oils of Lippia alba, Lippia origanoides,
Oreganum vulgare and Artemisia vulgaris on yellow fever virus (YFV) replication was investigated.
Methods: The cytotoxicity (CC50) on Vero cells was evaluated by the MTT reduction method.
The minimum concentration of the essential oil that inhibited virus titer by more than 50% (MIC)
was determined by virus yield reduction assay. YFV was incubated 24 h at 4°C with essential oil
before adsorption on Vero cell, and viral replication was carried out in the absence or presence of
essential oil. Vero cells were exposed to essential oil 24 h at 37°C before the adsorption of
untreated-virus.
Results: The CC50 values were less than 100 μg/mL and the MIC values were 3.7 and 11.1 μg/mL.
The CC50/MIC ratio was of 22.9, 26.4, 26.5 and 8.8 for L. alba, L origanoides, O. vulgare and A. vulgaris,
respectively. The presence of essential oil in the culture medium enhances the antiviral effect: L.
origanoides oil at 11.1 μg/mLproduced a 100% reduction of virus yield, and the same result was
observed with L. alba, O. vulgare and A. vulgaris oils at100 μg/mL. No reduction of virus yield was
observed when Vero cells were treated with essential oil before the adsorption of untreated-virus.
Conclusion: The essential oils evaluated in the study showed antiviral activities against YFV. The
mode of action seems to be direct virus inactivation.
Background
Yellow fever (YF) is a viral hemorrhagic fever endemic in
South America and sub-Saharan Africa. It is caused by the
yellow fever virus (YFV) that is transmitted to humans
through the bite of the Aedes or Haemagogus mosquitoes
[1]. YFV, belonging to the Flavivirus genus, is a single-
stranded RNA genome virus that possess a spherical
nucleo-capsid surrounded by a lipid envelop in which the
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envelope (E) protein and membrane (M) protein are
embedded. Binding of YFV to the cell surface is believed
to be mediated by the E protein [2].
Classical YF illness characterized by abrupt fever, myalgia,
headache and conjunctival injection is a self-limiting dis-
ease. Few patients (15%) develop severe disease with
jaundice, renal dysfunction, myocardial injury, and a
bleeding diathesis. Within this group of patients, 20 to
50% end fatally [1]. The World Health Organization esti-
mates that at least 200,000 cases of YF are reported each
year, including 30,000 deaths [3]. This is despite that YF is
prevented by vaccination with a live attenuated strain
(17D) of the YFV [4]. Although the 17D vaccine has a long
record of safety, in a few vaccinees (1:200,000 –
1:300,000) the virus can cause adverse events, such as
meningoencephalitis or an acute viral hemorrhagic syn-
drome with multiple organ system failure. The fatality rate
in cases suffering from disease due to 17D vaccination is
60% [4,5]. There is no currently approved antiviral drug
against YF.
Numerous studies have been conducted exploring differ-
ent approaches to antiviral compounds against YFV. These
include, chemical compounds focused at virus replication
interruption or at inhibition of a specific host pathway
critical to virus replication without undue toxicity; and
strategies aimed at modulation of host immune response
using passive antibodies, immunomodulators and corti-
costeroids [6]. Although some of those approaches have
shown promising results, any of them has yet to be
approved for use in humans.
Natural products are an important source to develop anti-
viral drugs, and they are selected frequently on the basis of
their ethno-medicinal use [7]. Several reports have dem-
onstrated direct inactivation and prevention of cell-to-cell
spread, of essential oils obtained from a varied number of
plants on enveloped viruses that cause human disease. [8-
14]. Nonetheless, little is known about antiviral effect on
Flavivirus. To our knowledge, studies evaluating antiviral
effect of essential oils against YFV have not been reported.
The objective of this study was to evaluate the inhibitory
effect of essential oils obtained from Lippia alba, Lippia
origanoides, Origanum vulgare and Artemisia vulgaris grown
in Colombia on YFV replication in vitro. Plants are widely
used all over the world to cure almost any disease. Infu-
sions are recommended against liver diseases; digestive,
spasmolitic and relieve stomach-ache; kidney pains; and
respiratory disorders. It is speculated that some of the
mentioned medicinal properties could be related to the
plant's essential oil compounds [15,16].
Methods
Essential oil
Propagation cuttings were obtained from L. alba and L.
origanoides growing wild in the surroundings of the Jordán
Sube township (Department of Santander). The cuttings
were used in establishing experimental contiguous plots
in the CENIVAM Agroindustrial Pilot Complex, located at
the main campus of Universidad Industrial de Santander
(Bucaramanga, Colombia). O. vulgare and A. vulgaris were
collected in Marinilla (Department of Antioquia) and
Armenia (Department of Quindio), respectively. Voucher
specimens from each plant were deposited at the Colom-
bian National Herbarium (COL), and the taxonomic
identifications were performed by Dr José Luis Fernández
(National Herbarium, UN, Bogotá, Colombia).
For all oils, the dried plant material was submitted to
microwave-assisted hydrodistillation in a Clevenger-type
apparatus, as described elsewhere [17]. Compound iden-
tification was based on chromatographic (retention times,
retention indices, standards) and spectroscopic (spectral
interpretation, comparison with databases and standards)
criteria [17,18]. Two GC-MS systems were employed, an
Agilent Technologies 6890 Plus gas chromatograph (Palo
Alto, CA, U.S.A.), equipped with an Agilent Technologies
5973N mass selective detector, and an Agilent Technolo-
gies 6890 gas chromatograph coupled to an Agilent Tech-
nologies 5975 mass selective detector. Both systems were
equipped with a split/splitless injector (split ratio 1:50), a
7863 automatic injector and an MS-ChemStation G1701-
DA data system that included the spectral libraries WILEY
138K, NIST 2002 and QUADLIB 2004. A fused silica cap-
illary column DB-5MS (J&W Scientific, Folsom, CA,
U.S.A.) of 60 m × 0.25 mm I.D. × 0.25 μm, df, and a fused
silica DB-WAX (J & W Scientific, Folsom, CA, U.S.A.) 60 m
× 0.25 mm, D.I × 0.25 μm, df column were employed. The
oven temperature was programmed from 45°C (5 min) to
150°C (2 min) at 4°C min-1, then to 250°C (5 min) at
5°C min-1, and finally, to 275°C (15 min) at 10°C min-1.
The ionization chamber and transfer line temperatures
were kept at 230°C and 285°C, respectively.
Plant local names, voucher numbers and the main essen-
tial oil components are shown in Table 1. For the antiviral
assays, the essential oil was dissolved in a solution of 1%
dimethyl sulfoxide (DMSO) in test medium.
Cell culture and virus
African green monkey kidney cells (Vero) were main-
tained in minimum essential medium (M-199) supple-
mented with 10% fetal calf serum (FCS) and 0.07%
NaHCO3 at 37°C in a humidified 5%-CO2 atmosphere.
The vaccine strain 17D of YFV was provided by the state
Secretariat of Health. Virus stocks were prepared by infect-Annals of Clinical Microbiology and Antimicrobials 2009, 8:8 http://www.ann-clinmicrob.com/content/8/1/8
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ing Vero cell cultures; the supernatant was collected 2–3
days post infection and stored at -70°C in aliquots.
Plaque assay
Virus titers were determined by plaque assays in Vero cells
growing in 24-well plates. Briefly, serial tenfold dilutions
of the viral suspension were added (0.1 mL/well) in dupli-
cate, and the cells were incubated for 1 h at 37°C. Subse-
quently, M-199 medium containing 5% FCS and 3%
carboxymethyl-cellulose (Sigma; 0.5 mL/well plates) was
added, and the plate was incubated for 72 h at 37°C. The
viral plaques were visualized after 10% formaldehyde fix-
ation (1 h at room temperature) and by staining (15 to 30
s) with a 1% crystal violet solution. The titer was esti-
mated by counting the number of plaques observed in
each well and expressed as plaque-formation unit per mil-
liliter (PFU/mL).
Cytotoxicity
Cell viability was measured on the basis of the mitochon-
drial-dependent reduction of MTT to formazan [19]. Vero
cells grown in a 96-well plate were treated with the essen-
tial oil at concentrations of 100, 33.3, 11.1 and 3.7 μg/mL
for 72 h at 37°C. Then, the culture medium was removed
and MTT solution (10 μL, 5 mg/mL, Sigma Co.) was
added to each well. The plate was incubated for 4 h at
37°C and DMSO (100 μL) was added to the wells to dis-
solve the MTT crystals. Each essential oil was tested in trip-
licate. The extent of MTT reduction to formazan within
the cells was quantified by measuring absorbance at 595
nm (OD595) on a multiwell spectrophotometer (Sensid-
ent Scan Merck). The 50% cytotoxic concentration (CC50)
was defined as the concentration that reduces the OD590
of treated cells to 50% with respect to untreated cells. The
CC50 values were calculated using the MSx/fitTM; ID Busi-
ness Solution, Guildford, UK software.
Viral inhibitory effect
The direct inactivation of YFV by the selected essential oils
was tested by using a virus yield reduction assay. The virus
(9.5 × 104 PFU) was incubated with concentrations of the
essential oil (100, 33.3, 11.1 and 3.7 μg/mL) for 24 h at
4°C in M-199 medium with 2% FCS. Treated-YFV was
used to infect monolayers of Vero cell grown in 24-well
plates at a multiplicity of infection of 1 PFU per cell (MOI
= 1). After a 1 h period at 37°C, the cells were washed
twice and then incubated at 37°C in M-199 medium con-
taining 5% FCS. Some experiments were also performed
incubating the virus-infected cells in M-199 medium con-
taining essential oil at concentrations described above. In
all assays, the supernatant, consisting of culture medium,
was collected and cleared by centrifugation at 400 × g at
4°C to determine the virus titer by the plaque assay
method 48 h after incubation of the plates. The results
were expressed as the lowest concentration of the essential
oil at which reduction of virus titer by more than 50%
(compared with control) was observed, and it was consid-
ered as the minimum inhibitory concentration (MIC).
The interference of the tested essential oils with the viral
cycle by treatment of cells before viral adsorption was
evaluated. Confluent monolayers of Vero cells grown in
24-well plates were exposed or not to the essential oil at
concentrations described above for 24 h at 37°C. The cells
were washed three times to remove residual oil, and then
were infected with untrated YFV at MOI of 1 for 1 h at
37°C. The cells were washed three times to remove resid-
ual oil, and then were infected with untreated-YFV at MOI
of 1 for 1 h at 37°C. After that, the unabsorbed virus were
removed by cell washes and the cells were incubated in M-
199 medium with 5% FCS at 37°C. At 48 h after incuba-
tion, the culture medium was collected and cleared by
Table 1: Plants used in the study and their main essential oil components
Specie (voucher) Local name Main essential oil components (%) Extraction yield (% p/p)
Lippia alba (CO 480750)* Pronto alivio Carvone (51) 0.4
Limonene (33)
bicyclosesquiphellandrene (7)
Lippia origanoides (CO 512075)* Orégano de monte Carvacrol (44) 3.5
Thymol (15)
γ-terpinene (10)
Origanum vulgare (CO 523701)† Orégano trans-Sabinene hydrate (21) 0.3
Thymol (11)
Carvacryl methyl ether (11)
γ-Terpineno (5.2)
p-Cimene (4.5)
Artemisia vulgaris (CO 517002)† Ajenjo α-Thujone (38.1) 0.1
β-Thujone (10.6)
1,8-Cineole (8.8)
trans-Carveol (3.1)
Sabineno (2.8)
Source: *, Ref. 17 and 18; †, this study.Annals of Clinical Microbiology and Antimicrobials 2009, 8:8 http://www.ann-clinmicrob.com/content/8/1/8
Page 4 of 6
(page number not for citation purposes)
centrifugation at 400 × g at 4°C to determine the virus
titer by the plaque assay method.
Results
Essential oils were tested for their cytotoxicity on Vero cell
prior to the determination of their inhibitory effect
against YFV. All essential oils were not cytotoxic. The CC50
for L. alba, L. origanoides, O. vulgare and A. vulgaris were 90
± 15, 98 ± 3.8, 98 ± 2.8 and 98 ± 2.9 μg/mL, respectively.
The abilities of the selected essential oils to directly inacti-
vate YFV (virucidal activities) were evaluated. Pre-incuba-
tion of virus with selected essential oil for 24 h at 4°C
before adsorption on Vero cell inhibited the subsequent
extracellular virus titer. The MIC for L. alba, L origanoides
and O. vulgare oils was 3.7 μg/mL whereas for A. vulgaris
was 11.1 μg/mL (Figure 1). The MIC was lower than the
CC50 for Vero cells, resulting a CC50/MIC ratio of 22.9,
26.4, 26.5 and 8.8 for L. alba, L origanoides, O. vulgare and
A. vulgaris, respectively. A noted increased virucidal effect
was observed with O. vulgare at concentrations higher
than the MIC (> 3.7 μg/ml), but the same was not
observed with the others essential oils. A poor (r = 0.72,
linear regression) concentration-dependent reduction was
observed with all essential oils.
The presence of essential oil in culture medium for 48 h
after the adsorption of treated-YFV on Vero cell monolay-
ers enhances the antiviral effect (Figure 2). Virus titer was
completely reduced in the presence of L. origanoides oil at
concentration of 11.1 μg/mL, or of L. alba, O. vulgare or A.
vulgaris oils at 100 μg/mL. This is, viral plaques were not
recovered from undiluted media, and viral antigen was
not detected on infected cells analyzed by microscopy-
immunofluorescence.
No inhibition was observed when cells were pre-incu-
bated with essential oil for 24 h at 37°C before the
adsorption of untreated-YFV. A significant reduction of
viral progeny was not observed with none of the tested
essential oils at concentration of 3.7, 11.1, 33.3 or 100 μg/
mL (Figure 3). The virus titer in supernatants of cell cul-
tures exposed to the essential oils did not show any differ-
ence with respect to the controls of untreated cells (p >
0.05, multiple regression).
Taken together, the results suggest that the action of essen-
tial oils as inhibitor agents of YFV infectivity is due to
direct virus inactivation, preventing the adsorption and
subsequent cellular infection.
Discussion and conclusion
The antiviral or virucidal effect is generally expressed as
IC50 (inhibitory concentration 50%). This is calculated by
regression analyses of the dose response curve generated
from the data. The IC50 value for all essential oils tested in
this study could not be determined. This is because of con-
centrations lower than 3.7 or 11.1 μg/mL were not tested
in order to investigate inhibition of virus titer by less than
50%. Consequently, we expressed virucidal activity as the
lowest concentration of essential oil at which inhibition
of virus titer by more than 50% was observed (MIC). On
Direct inactivation of essential oils from Colombian plants on  yellow fever virus (YFV) Figure 1
Direct inactivation of essential oils from Colombian 
plants on yellow fever virus (YFV). About 9.5 × 104 PFU 
of YFV were incubated for 24 h at 4°C with concentrations 
of essential oil and then were adsorbed on Vero cells. Virus 
titers in supernatants of cell cultures were determined by 
plaque assays method at 48 h after adsorption. The data rep-
resent the means for three replicate samples of two inde-
pendent experiment. Error bars indicate standard deviations.
Increase of direct yellow fever virus (YFV) inactivation by the  presence of essential oil in the supernatant of virus-infected  cells culture Figure 2
Increase of direct yellow fever virus (YFV) inactiva-
tion by the presence of essential oil in the superna-
tant of virus-infected cells culture. YFV previously 
incubated with serial dilutions of essential oil (Figure 1) was 
replicated in Vero cells at 37°C in M-199 medium containing 
varied concentration of essential oil. Virus titers in superna-
tants of cell cultures were determined by plaque assays 
method at 48 h after adsorption. The data represent the 
means for three replicate samples of two independent exper-
iment. Error bars indicate standard deviations.Annals of Clinical Microbiology and Antimicrobials 2009, 8:8 http://www.ann-clinmicrob.com/content/8/1/8
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the other hand, definite essential oil concentration-
dependent reduction was not observed (Figure 1). We
could speculate that this result could be due to the
strength of binding between virus and components of the
essential oil which determines the fraction of molecules
on the virus particle occupied by the oil. Even complete
occupancy by using higher concentrations of the oil it
could not be sufficient to increase the virus inhibition.
One method commonly used for evaluation of in vitro
antiviral effect involves titration of residual virus infectiv-
ity after extracellular action of the test substance using a
plaque reduction assay. Generally, this assay is run 1 h at
37°C or room temperature, and when the assay is per-
formed at 4°C it is assumed that the inhibition may be
lower [20]. Sadii et al. [10] found that the antiviral effect
of essential oil obtained from Artemisia arborescens against
enveloped Herpes Simplex virus type 1 was higher when
the mixture virus-oil was incubated at 37°C than at 4°C.
We evaluated the direct inactivation on YFV by essential
oils from plants grown in Colombia in assays run at 4°C,
using titration of residual virus in stored supernatant by
using plaque assay method instead of direct reduction of
viral plaque. Even with these limitations, the essential oils
screened showed direct inactivation on YFV at MIC values
as low as 3.7 and 11.1 μg/mL (Figure 2).
In this study, the direct YFV inactivation by selected essen-
tial oils was tested without any virus-oil mixture dilution
to eliminate the oil. On the other hand, essential oil was
added to culture medium after adsorption of treated-YFV.
Consequently, the assays might not allow to precisely dis-
criminate between antiviral and virucidal action because
the oil could enter into the cells and interfere with intrac-
ellular steps of the viral cycle. As shown in Figure 3, we did
not observe decrease of viral progeny when the cells were
exposed 24 h to high concentration (100 μg/mL) of the
essential oil and then were infected with untreated-YFV.
This result suggests that changes on the plasmatic mem-
brane cell or intracellular environment that could inter-
fere with the adsorption or intracellular steps of the viral
cycle were not induced. It was demonstrated that the pres-
ence of tested essential oils in culture medium during rep-
lication of treated-YFV enhances the inhibitory effect. This
enhancement could be more probably due to direct inac-
tivation of virus released from infected cells than inhibi-
tion of the penetration or protein synthesis steps of the
viral cycle. Our results are in agreement with studies with
other enveloped virus. The in vitro replication abilities of
HSV [8-11,21-24], Human Immmodeficiency virus [12]
and Hepatits B virus [13] were suppressed by previous
exposition to essential oils obtained from plants from var-
ious countries, but antiviral activity was not observed by
treatment of the cell with essential oil before the adsorp-
tion of the virus.
Supported studies of antiviral effect of essential oils on
YFV were not found. Concerning antiviral activity on oth-
ers members of the Flaviviridae family, two studies with
dengue virus (DENV) have been reported. Duschatzky et
al. [14] and Garcia et al. [25] did not observe significant
antiviral effect on DENV-2 by essential oils obtained from
eight species of aromatic plants from Argentina. Only A.
douglasiana  and E. patens had any discernible virucidal
effect. We have carried out experiments for evaluation of
direct inactivation on DENV-2 by essential oils from six
plants grown in Colombia. L. origanoides and Hyptis sp
showed a 50% reduction of the virus titer at concentration
of 100 μg/mL, whereas Piper auritum, Piper ottoniifolium, L.
alba and Thymus vulgaris did not show activity (unpub-
lished data).
It is speculated that direct virus inactivation by the essen-
tial oils can be due to disruption of the viral membrane by
lipophilic compounds [24], but the precise mechanism of
the antiviral action is still not fully understood. The major
components in the essential oil extracted from plants are
terpenes and terpenoids. Several kinds of these com-
pounds have been shown to inhibit HIV, and it was dem-
onstrated that their anti-HIV activity involves inhibition
of virus adsorption to target cell, and causing inactivation
of HIV reverse transcriptase [26-29]. The major compo-
nents of the essential oils tested in this study were car-
vone, carvacrol, limonene and thymol, and the presence
of these compounds could in part explain the virucidal
effect on YFV. More studies should be conducted to
explore the mechanism of interference with viral intracel-
lular process of the compounds present in the essential
oils.
Absence of antiviral effect of essential oils from Colombian  plants on YFV replication by treatment of host cell Figure 3
Absence of antiviral effect of essential oils from 
Colombian plants on YFV replication by treatment 
of host cell. Vero cells were exposed to varied concentra-
tion of essential oil for 24 h at 37°C before YFV infection 
(MOI = 1). Virus titers in supernatants of cell cultures were 
determined by plaque assays at 48 h after adsorption. The 
data represent the means for three replicate samples of two 
independent experiment. Error bars indicate standard devia-
tions.Annals of Clinical Microbiology and Antimicrobials 2009, 8:8 http://www.ann-clinmicrob.com/content/8/1/8
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The present study has demonstrated the inhibitory effect
of the essential oils obtained from L. origanoides, O. vul-
gare, L. alba, and A. vulgaris cultivated in Colombiaon YFV.
The results obtained stimulate further investigation in
order to know the antiviral activity of each compound
present in the essential oil, and to determine whether or
not synergism between them is responsible for that activ-
ity.
The topical use of essential oil might be explored for pre-
vention of virus infection through the bite of the mosqui-
toes vectors.
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